Clinical Evaluation of resin- based calcium direct pulp capping materials.

Evaluation Of Clinical Success of Three Resin Based Calcium Silicate Materials as Direct Pulp Capping Agents: A Randomized Clinical trial - NIL

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068313

Enrollment

Registered

2024-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified Health Condition 2: K029- Dental caries, unspecified

Interventions

Intervention1: Theracal PT Bisco incorporations: Theracal PT is a pulp protection material specially designed for pulpotomy procedures and it can also be approved for other pulp therapies like direct

Eligibility

Inclusion criteria

Inclusion criteria: patients who are asymptomatic/symptomatic reversible pulpitis with deep dental caries in posterior teeth close to pulp chamber and bleeding easily controlled after pulp exposure

Exclusion criteria

Exclusion criteria: any h/o of spontaneous pain, periapical lesion and bleeding not controlled after pulp exposure

Design outcomes

Primary

Measure	Time frame
MORE THAN 75% OF PATIENTS RECIIEVING DIRECT PULP CAPPING BY THE MATERIALS USED IN THE STUDY WILL BE CAPABLE OF PRESERVING THE PULP VITALITYTimepoint: WITHIN 3 MONTHS	—

Secondary

Measure	Time frame
IN MORE THE 75% PATIENTS THE SIGNS AND SYMPTOMS OF PULPITIS SUCH AS TOOTH ACHE WILL BE CUREDTimepoint: WITHIN 3 MONTHS	—

Countries

India

Contacts

Public ContactYellapu Shenkari Indumathi

Drs. Sudha & Nageswara Rao Siddhartha Institute of Dental Sciences

drkumarjanga@gmail.com7032491930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026